Xconomy: Robotics and A.I.

National
Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More

1.
Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More | National
2.
Generate Bio Aims to Reveal Nature’s Protein Secrets, Create New Drugs | Boston
3.
Two Days, Six IPOs, and $1B Raised for Biotech Research & More | National
4.
Data Quantity, Complexity Drives Use of AI in Drug Discovery and Testing | San Francisco
5.
Akili Interactive’s Video Game for ADHD Gets the FDA All Clear | Boston
6.
Biotech “Mapmaker” Immunai Launches With $20M to Chart the Immune System | New York

Pliant Pushes Forward With IPO Plans to Back Fibrosis Drug Studies
Frank Vinluan | San Francisco
Lantern Pharma IPO File Illuminates Plan to “Rescue” Failed Cancer Drugs
Frank Vinluan | Texas
Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More
Frank Vinluan | National
Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA
Frank Vinluan | National
Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More
Sarah de Crescenzo | National
Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More
Frank Vinluan | National
AI Can Unlock Health Data’s Potential, But Access Is Still Difficult
Jeff Bauter Engel | Wisconsin
AstraZeneca Chooses China for R&D and AI Centers, $1B Biotech Fund
Gareth Macdonald | National
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
Frank Vinluan | National

Read More Posts ›

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
How to Approach Life Sciences Fundraising
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

Sponsored · Webinar
Sept. 15 – Challenges of Implementing Innovation in Drug Discovery & Development
Phenotypic Screening & Profiling to Understand a Compound's Disease Impact
Eurofins Discovery

Sponsored · Video
Fish & Richardson: Patent Law in Regards to AI and Machine Learning
A Fireside Chat with Fish & Richardson Principal Teresa Lavoie
Fish & Richardson

Xconomy on Demand

We offer a number of ways to subscribe for free!